Revenue: The sum of all revenue fields included for a company's operating activities.
10x Genomics (TXG) had Revenue of $618.73M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$618.73M |
$-255.10M |
|
$209.41M |
|
$409.31M |
|
$884.06M |
|
$-265.33M |
|
$16.57M |
|
$-248.76M |
|
$-248.76M |
|
$-255.10M |
|
$-255.10M |
|
$-255.10M |
|
$-255.10M |
|
$-265.33M |
|
$-221.71M |
|
117.17M |
|
117.17M |
|
$-2.18 |
|
$-2.18 |
|
| Balance Sheet Financials | |
$596.02M |
|
$279.57M |
|
$369.12M |
|
$965.14M |
|
$127.16M |
|
-- |
|
$96.94M |
|
$224.10M |
|
$741.04M |
|
$719.92M |
|
$741.04M |
|
119.10M |
|
| Cash Flow Statement Financials | |
$-15.20M |
|
$133.49M |
|
$13.67M |
|
$227.35M |
|
$359.28M |
|
$131.93M |
|
$166.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
66.15% |
|
-42.88% |
|
-42.88% |
|
-35.83% |
|
-40.21% |
|
-41.23% |
|
$-63.80M |
|
-- |
|
-- |
|
-- |
|
0.64 |
|
2.84 |
|
5.39 |
|
67.74 |
|
-34.42% |
|
-35.43% |
|
-26.43% |
|
-34.42% |
|
$6.22 |
|
$-0.54 |
|
$-0.13 |
|